Short answer
Baxter International (BAX) filed an 8-K current report with the SEC on April 30, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). Earnings release covers the quarter ended March 31, 2026.
Baxter International 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Earnings release covers the quarter ended March 31, 2026
- Exhibit 99.1 contains Baxter’s earnings press release and attachments
- Investor focus: quarterly results, guidance, and management commentary in Exhibit 99.1
Item 8.01 · Other Events
- Quarterly cash dividend declared at $0.01 per common share
- Payable July 1, 2026, to shareholders of record May 29, 2026
- Dividend declaration signals continued shareholder-return commitment but at a modest per-share amount
Item EX-99.1 · Exhibit EX-99.1
- Q1 sales $2.7B, up 3% reported but down 1% organically, signaling limited underlying growth
- GAAP continuing-operations loss $0.03 per share versus adjusted EPS $0.36, with tariffs and manufacturing costs pressuring profitability
- U.S. sales fell 4% organically, while international sales grew 3%, highlighting geographic divergence
- Infusion pump weakness continued amid the Novum IQ shipment and installation hold
- Full-year outlook reiterated: organic sales approximately flat and adjusted EPS $1.85–$2.05
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Baxter International 8-K filings
Get the next BAX 8-K as it lands
Follow BAX for push alerts, or ask the research agent what this filing means.